| Authors: |
Zarka J; Department of Medical Oncology, Mayo Clinic, Rochester, MN; Division of Hematology, Mayo Clinic, Rochester, MN. Electronic address: zarka.jabra@mayo.edu., Juthani R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Sartor O; Department of Medical Oncology, East Jefferson General Hospital Cancer Center, New Orleans, LA., Muniz M; Department of Medical Oncology, Mayo Clinic, Rochester, MN., Kase AM; Department of Medical Oncology, Mayo Clinic, Jacksonville, FL., Riaz IB; Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ., Naqvi A; Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ., Heath E; Department of Medical Oncology, Mayo Clinic, Rochester, MN., Orme JJ; Department of Medical Oncology, Mayo Clinic, Rochester, MN., Scharf Z; Department of Medical Oncology, Mayo Clinic, Rochester, MN., Belge Bilgin G; Department of Radiology, Division of Nuclear Medicine, Mayo Clinic, Rochester, MN., Kwon ED; Department of Urology, Mayo Clinic, Rochester, MN., Jang A; Department of Medical Oncology, Mayo Clinic, Rochester, MN., Tarhini A; Department of Medical Oncology, Mayo Clinic, Rochester, MN., Johnson GB; Department of Radiology, Division of Nuclear Medicine, Mayo Clinic, Rochester, MN., Kendi AT; Department of Radiology, Division of Nuclear Medicine, Mayo Clinic, Rochester, MN., Thorpe MP; Department of Radiology, Division of Nuclear Medicine, Mayo Clinic, Rochester, MN., Patnaik MS; Division of Hematology, Mayo Clinic, Rochester, MN., Kusne Y; Division of Hematology, Mayo Clinic, Rochester, MN., Jacene H; Department of Imaging, Dana-Farber Cancer Institute, Boston, MA., Ravi P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Childs DS; Department of Medical Oncology, Mayo Clinic, Rochester, MN. |
